| % ID/cc | percentage of injected dose per cubic centimeter of tissue |
| % ID/g | percentage of injected dose per gram of tissue |
| 225Ac | Actinium-225 |
| APP | amyloid peptide precursor |
| BBB | blood–brain barrier |
| BTB | brain-tumor barrier |
| CDR | complementary-determining region |
| CH1/CH2/CH3 | constant domain 1/2/3 of heavy chain |
| CNS | central nervous system |
| GFAP | glial fibrillary acidic protein |
| GFP | green fluorescence protein |
| HCAb | heavy-chain antibody |
| HER | human epidermal growth factor receptor |
| 131I | Iodine-131 |
| ID | injected dose |
| IGF1R | insulin-like growth factor 1 receptor |
| IgG | immunoglobulin G |
| 111In | Indium-111 |
| NMDAR | N-Methyl-D-Aspartate receptor |
| PDL1 | program death-ligand 1 |
| PET | PET |
| RMT | receptor-mediated transcytosis |
| sDAb | single-domain antibody |
| 99mTc | Technetium-99m |
| TfR | transferrin receptor |
| VCAM1 | vascular cell adhesion molecule 1 |
| VCAMelid | VHH against VCAM1 |
| VEGF | vascular endothelium growth factor |
| VH | variable domain of conventional antibodies heavy chain |
| VL | variable domain of conventional antibodies light chain |
| VHH | variable domain of heavy-chain antibodies |
| VHHs | plural of VHH |
| VNAR | variable new antigen receptor |
| WT | wild-type |
| 89Zr | Zirconium 89 |